{"version":"1.0","type":"link","title":"Prognostic Value of Baseline Systemic Immune-Inflammation Index in Advanced Intrahepatic Cholangiocarcinoma Treated with First-Line Gemcitabine-Cisplatin Plus PD-L1 Inhibitor: A Single-Center Retrospective Study.","author_name":"Wu S 외","author_url":"https://prs-insight.online/author/Wu%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/168232","thumbnail_width":1200,"thumbnail_height":630}